Results 91 to 100 of about 23,000 (252)

Systematic Review of Postvaccination Ocular Adverse Events: A Comprehensive Analysis of Published Reports

open access: yesJournal of Medical Virology, Volume 97, Issue 12, December 2025.
ABSTRACT Ocular adverse events following COVID‐19 vaccination are well described; however, systematic analyses of non‐COVID antiviral vaccines remain limited. This review aimed to evaluate ocular complications associated with non‐COVID antiviral immunizations, including influenza, varicella‐zoster (VZV), human papillomavirus (HPV), and hepatitis B (HBV)
Yaru Zou   +5 more
wiley   +1 more source

The rationale for integrated childhood meningoencephalitis surveillance: a case study from Cambodia

open access: yesBulletin of the World Health Organization, 2009
PROBLEM: Recent progress in vaccine availability and affordability has raised prospects for reducing death and disability from neurological infections in children.
Sok Touch   +6 more
doaj  

Culex tarsalis is a competent vector species for Cache Valley virus [PDF]

open access: yes, 2018
Background: Cache Valley virus (CVV) is a mosquito-borne orthobunyavirus endemic in North America. The virus is an important agricultural pathogen leading to abortion and embryonic lethality in ruminant species, especially sheep.
Alto, Barry W.   +10 more
core   +1 more source

Polyethylene Glycol‐Functionalized Graphene Oxide Nanocomposites: Advances in Biomedical Applications

open access: yesNano Select, Volume 6, Issue 12, December 2025.
Polyethylene glycol‐functionalized graphene oxide (PEG‐GO) nanocomposites revolutionize nanomedicine with their high surface area and tunable properties. This review explores their synthesis, characterization, and applications in drug delivery, gene therapy, biosensing, and photothermal therapy.
Oluwasegun Chijioke Adekoya   +4 more
wiley   +1 more source

Efficacy and safety of anifrolumab across organ domains of systemic lupus erythematosus: A systematic review and meta‐analysis

open access: yesRheumatology &Autoimmunity, Volume 5, Issue 4, Page 285-296, December 2025.
A systematic review and meta‐analysis were conducted to review all clinical trial results of anifrolumab for treating systemic lupus erythematosus. Fourteen studies were included comprising 1322 patients and five studies were meta‐analyzed. It was found that anifrolumab 300 mg IV led to clinical improvement across composite lupus scores, cutaneous ...
Yomna W. Mahmoud   +11 more
wiley   +1 more source

Partial cross-protection between Japanese encephalitis virus genotype I and III in mice.

open access: yesPLoS Neglected Tropical Diseases, 2019
Genotype III (GIII) Japanese encephalitis virus (JEV) predominance has gradually been replaced by genotype I (GI) over the last 20 years in many Asian countries.
Jianchao Wei   +12 more
doaj   +1 more source

AB5-Type Toxin as a Pentameric Scaffold in Recombinant Vaccines against the Japanese Encephalitis Virus [PDF]

open access: gold, 2023
Jina Ahn   +6 more
openalex   +1 more source

Bibliography on inactivation of viruses and rickettsiae by heat [PDF]

open access: yes
Inactivation of viruses and rickettsiae by heat ...
Homann, L. M., Watson, M. S.
core   +1 more source

Outbreak of Zika virus pathogenesis and quest of its vaccine development: Where do we stand now? [PDF]

open access: yes, 2018
Zika virus (ZIKV) infection is a life-threatening tropical infection, mainly caused by mosquito bite. After a very long period of quietness, ZIKV infections have become a problematic issue again.
Aarti, Chirom   +7 more
core   +1 more source

Prevention, diagnosis, and management of Japanese encephalitis in children

open access: yesPediatric Health, Medicine and Therapeutics, 2014
Rashmi Kumar Department of Pediatrics, King George Medical University, Lucknow (UP), India Abstract: Japanese encephalitis is the single largest cause of viral encephalitis in the world today.
Kumar R
doaj  

Home - About - Disclaimer - Privacy